KANNAPOLIS, N.C.--(BUSINESS WIRE)--David H. Murdock announced today that an affiliate of his Castle & Cooke, Inc. has committed $33 million to a therapeutic vaccine company. The monies are being used to fund its operations and its proposed Phase III trial with the Food and Drug Administration (FDA).
